AdaptX Funding: How Much Did They Raise & Key Investors

How Much Did AdaptX Raise?
Funding & Key Investors

AdaptX, a Seattle-based innovator in clinical management technology, has successfully secured a significant capital injection, bringing its total funding to $13.1M. This latest major strategic investment of $2.7M underscores the company's pivotal role in the digital transformation of health systems. By leveraging real-world data to optimize clinical workflows, AdaptX continues to attract substantial backing from both institutional investors and strategic healthcare partners, solidifying its trajectory as a leader in the enterprise health technology sector.

The recent financing round, finalized in late 2025, serves as a testament to the market's confidence in the company's proprietary AI-driven Mission Control Center. As health systems face increasing pressure to improve patient outcomes while maintaining financial sustainability, AdaptX provides the necessary analytical infrastructure to bridge the gap between raw clinical data and actionable operational intelligence.

What is AdaptX?

AdaptX

Software

Healthcare Software

Business Intelligence (BI) Software

Founded in 2016, AdaptX specializes in self-serve Adaptive Clinical Management solutions designed to empower clinical leaders. The company's core platform functions as a Mission Control Center, enabling healthcare organizations to assess performance, compare clinical approaches, and refine protocols across diverse patient populations and facilities. By integrating AI-driven insights into daily workflows, AdaptX enables health systems to achieve superior patient care and optimized financial performance. The platform's ability to synthesize complex, real-world data into intuitive dashboards positions AdaptX as a critical partner for modern, data-centric healthcare providers looking to scale their operational efficiency.

How much funding has AdaptX raised?

AdaptX has raised a total of $13.1M across 3 funding rounds:

2023

Other Financing Round

$10M

2025

Stock/Share Issuance

$2.7M

Debt

$450K

Other Financing Round (2023): $10M with participation from Memorial Hermann and Morningside Ventures

Stock/Share Issuance (2025): $2.7M, investors not publicly disclosed

Debt (2025): $450K, investors not publicly disclosed

Key Investors in AdaptX

Memorial Hermann

Memorial Hermann Health System is a prominent not-for-profit healthcare organization based in Houston, Texas, providing comprehensive medical services and specialty care across the region.

Morningside Ventures

Morningside Ventures is an investment firm focused on information and document management, providing strategic capital to innovative technology enterprises.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for AdaptX?

With this latest infusion of capital, AdaptX is well-positioned to accelerate its product development roadmap and expand its footprint within the enterprise healthcare market. The strategic focus will likely center on enhancing the predictive capabilities of its Mission Control Center and deepening integrations with existing electronic health record systems. As the company moves beyond its initial growth phase, the emphasis will shift toward scaling its sales and implementation teams to meet the rising demand for adaptive clinical management tools. By maintaining its commitment to data-driven decision-making, AdaptX is poised to redefine the standards of clinical excellence and operational agility in the healthcare industry.

See full AdaptX company page

See More Financial Insights